Gadolinium and gait disturbance Patient Reports February 11, 2012

Gadolinium Side Effects Report #5141522-8
Gadolinium side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Male patient, 64 years of age, weighting 185.0 lb, was diagnosed with renal failure chronic and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: dysstasia, gait disturbance, ill-defined disorder, renal transplant, skin hypertrophy. Gadolinium dosage: unknown. Patient recovered.

Gadolinium Side Effects Report #5619565-7
Gadolinium side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 05, 2008. Female patient, 56 years of age, weighting 245.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: dyspnoea, gait disturbance, malaise, musculoskeletal chest pain, oedema peripheral, pain in extremity, pelvic pain , skin burning sensation, skin inflammation. Gadolinium dosage: unknown. Patient recovered.

Gadolinium Side Effects Report #6024663-2
Gadolinium side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 30, 2008. Male patient, 45 years of age, weighting 225.0 lb, was diagnosed with multiple sclerosis  and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: blood arsenic increased, gait disturbance, skin fibrosis. Gadolinium dosage: unknown. Patient recovered.

Gadolinium Side Effects Report #5046134-2
Gadolinium side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, weighting 249.1 lb, was diagnosed with abscess , muscle necrosis and was treated with Gadolinium. After drug was administered, patient experienced the following side effects: castleman's disease, cellulitis , gait disturbance, hodgkin's disease , mobility decreased, muscle necrosis, myositis , nephrogenic fibrosing dermopathy, non-hodgkin's lymphoma. Gadolinium dosage: unknown. During the same period patient was treated with GADOLINIUM MRI CONTRAST DYE, GADOLINIUM MRI CONTRAST DYE, GADOLINIUM MRI CONTRAST DYE. Patient was hospitalized. Patient recovered.